Corneal subepithelial opacity inhibitor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/195 (2006.01) A61K 9/08 (2006.01) A61K 31/192 (2006.01)

Patent

CA 2266363

The present invention relates to a corneal subepithelial opacity (haze) inhibitor comprising as the active ingredient N-(3,4-dimethoxycinnamoyl)anthranilic acid represented by the formula: (see formula I) or a pharmaceutically acceptable salt thereof, is useful for the prevention or treatment of corneal subepithelial opacity (haze) caused by a wound during the operation of refractive surgery such as keratectomy and radial keratotomy, and an external wound.

L'invention concerne un inhibiteur de turbidité sous-epithéliale contenant comme principe actif un acide N-(3,4-diméthoxycinnamoyle)anthranilique représenté par la formule (I), ou bien ses sels acceptables pharmacologiquement, utile dans la thérapie cornéenne de réfraction, telle que le retrait de la partie antérieure de la cornée et la couverture de la zone dénudée avec une conjonctive bulbaire ou une kératotomie radiale, et dans la prévention ou la guérison d'une turbidité sous-épithéliale provoquée par des lésions accompagnées d'un trauma cornéen.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Corneal subepithelial opacity inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Corneal subepithelial opacity inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Corneal subepithelial opacity inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1889222

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.